NCT05222620View on ClinicalTrials.gov

SRS Compared With FSRS for Treatment of Intact Metastatic Brain Disease, FRACTIONATE Trial

PHASE2RecruitingINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

March 14, 2022

Primary Completion Date

February 15, 2027

Study Completion Date

February 15, 2028

Conditions
Metastatic Malignant Neoplasm in the BrainMetastatic Malignant Solid Neoplasm
Interventions
OTHER

Questionnaire Administration

Ancillary studies

RADIATION

Stereotactic Radiosurgery

Undergo single fraction SRS

RADIATION

Stereotactic Radiosurgery

Undergo fractionated SRS

PROCEDURE

Magnetic Resonance Imaging

Undergo MRI

Trial Locations (7)

32224

RECRUITING

Mayo Clinic in Florida, Jacksonville

54601

RECRUITING

Mayo Clinic Health System-Franciscan Healthcare, La Crosse

54701

RECRUITING

Mayo Clinic Health System-Eau Claire Clinic, Eau Claire

55905

RECRUITING

Mayo Clinic in Rochester, Rochester

56001

RECRUITING

Mayo Clinic Health Systems-Mankato, Mankato

56007

NOT_YET_RECRUITING

Mayo Clinic Health System in Albert Lea, Albert Lea

85259

RECRUITING

Mayo Clinic in Arizona, Scottsdale

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT05222620 - SRS Compared With FSRS for Treatment of Intact Metastatic Brain Disease, FRACTIONATE Trial | Biotech Hunter | Biotech Hunter